动态自旋回波与梯度回波平面成像MRI同时定量脑胶质瘤灌注、渗透性和渗漏效应
研究前瞻性纳入38例强化脑胶质瘤患者,用动态SAGE-EPI单次注射对比剂同时获取DSC、DCE及渗漏效应指标,比较治疗初治与复发亚组及IDH状态、Ki67表达的关系。结果表明该技术可同时定量灌注与渗透性,并提供反映血脑屏障破坏和细胞构筑的新指标;在初治胶质瘤中TRATE>142 mM-1s-1仅见于初治IDH野生型,预测Ki67>10%的敏感度89%、特异度80%。
要点
- 动态SAGE-EPI单次注射对比剂即可同时获得DSC灌注指标和DCE渗透性指标。
- TRATE>142 mM-1s-1仅见于初治IDH野生型胶质瘤,预测Ki67>10%敏感度89%、特异度80%。
- IDH野生型中既往治疗与更低TRATE、更高PSR、Ktrans、ΔR1,ss、ve和ADC相关。
核心结论
- 动态SAGE-EPI可单次注射对比剂同时定量脑肿瘤灌注和渗透性,并映射反映细胞构筑(TRATE)和血脑屏障破坏(ΔR1,ss)的新指标。
研究设计与样本
- 前瞻性研究纳入38例强化脑胶质瘤患者,采用动态SAGE-EPI成像并计算传统DSC指标(nrCBV、PSR)、DCE指标(Ktrans、ve)及渗漏效应指标(ΔR2,ss*、ΔR1,ss、TRATE)。
- 比较治疗初治(TN)与复发(R)亚组及IDH状态、Ki67表达等生物学特征。
关键影像表现/征象
- IDH野生型胶质瘤中,既往治疗暴露者TRATE更低(p=0.002),PSR更高(p=0.006),Ktrans更高(p=0.17),ΔR1,ss更高(p=0.035),ve更高(p=0.006),ADC更高(p=0.016)。
- IDH突变型胶质瘤中,既往治疗者Ktrans和ΔR1,ss更高(p=0.026)。
- 初治胶质瘤中,动态SAGE-EPI指标倾向受IDH状态影响(p范围0.09-0.14)。
- TRATE>142 mM-1s-1仅见于初治IDH野生型胶质瘤。
诊断标准与关键数值
- 在初治胶质瘤中,TRATE>142 mM-1s-1预测Ki67>10%的敏感度为89%、特异度为80%。
临床应用与阅片要点
- 动态SAGE-EPI可减少扫描时间和对比剂剂量,减轻对成像方案时长和钆剂不良反应及蓄积的担忧,同时提供反映血脑屏障破坏和肿瘤组织细胞构筑的新渗漏效应指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the feasibility and biologic correlations of dynamic susceptibility contrast (DSC), dynamic contrast enhanced (DCE), and quantitative maps derived from contrast leakage effects obtained simultaneously in gliomas using dynamic spin-and-gradient-echo echoplanar imaging (dynamic SAGE-EPI) during a single contrast injection.
MATERIALS AND METHODS: Thirty-eight patients with enhancing brain gliomas were prospectively imaged with dynamic SAGE-EPI, which was processed to compute traditional DSC metrics (normalized relative cerebral blood flow [nrCBV], percentage of signal recovery [PSR]), DCE metrics (volume transfer constant [Ktrans], extravascular compartment [ve]), and leakage effect metrics: ΔR2,ss* (reflecting T2*-leakage effects), ΔR1,ss (reflecting T1-leakage effects), and the transverse relaxivity at tracer equilibrium (TRATE, reflecting the balance between ΔR2,ss* and ΔR1,ss). These metrics were compared between patient subgroups (treatment-naïve [TN] vs recurrent [R]) and biological features (IDH status, Ki67 expression).
RESULTS: In IDH wild-type gliomas (IDHwt-i.e., glioblastomas), previous exposure to treatment determined lower TRATE (p = 0.002), as well as higher PSR (p = 0.006), Ktrans (p = 0.17), ΔR1,ss (p = 0.035), ve (p = 0.006), and ADC (p = 0.016). In IDH-mutant gliomas (IDHm), previous treatment determined higher Ktrans and ΔR1,ss (p = 0.026). In TN-gliomas, dynamic SAGE-EPI metrics tended to be influenced by IDH status (p ranging 0.09-0.14). TRATE values above 142 mM-1s-1 were exclusively seen in TN-IDHwt, and, in TN-gliomas, this cutoff had 89% sensitivity and 80% specificity as a predictor of Ki67 > 10%.
CONCLUSIONS: Dynamic SAGE-EPI enables simultaneous quantification of brain tumor perfusion and permeability, as well as mapping of novel metrics related to cytoarchitecture (TRATE) and blood-brain barrier disruption (ΔR1,ss), with a single contrast injection.
CLINICAL RELEVANCE STATEMENT: Simultaneous DSC and DCE analysis with dynamic SAGE-EPI reduces scanning time and contrast dose, respectively alleviating concerns about imaging protocol length and gadolinium adverse effects and accumulation, while providing novel leakage effect metrics reflecting blood-brain barrier disruption and tumor tissue cytoarchitecture.
KEY POINTS: • Traditionally, perfusion and permeability imaging for brain tumors requires two separate contrast injections and acquisitions. • Dynamic spin-and-gradient-echo echoplanar imaging enables simultaneous perfusion and permeability imaging. • Dynamic spin-and-gradient-echo echoplanar imaging provides new image contrasts reflecting blood-brain barrier disruption and cytoarchitecture characteristics.
引用
- Sanvito F, Raymond C, Cho NS, et al. Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. Eur Radiol. 2023. PMID: 37882836. doi:10.1007/s00330-023-10215-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。